$PGLC / $T.PGLC Mining Stock Media Alert for Pershing Gold

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

The Heartbeat of Innovation in Cancer Therapy Who would've thought Tennessee would be at the forefront of a global push against lung cancer? Sure, there's Nashville's music scene, but it's the researchers at Tennessee Oncology who are grooving to a different beat—one that might just set the rhythm for advanced cancer therapies worldwide. Yeah, it's a trial, but not just...

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...

The Ripple Effect of Tragedy Grief has a way of shaking a community down to its core—especially when the loss emanates from such senseless violence as the shooting death of 17-year-old Levi Brown. This wasn't just a tragic occurrence at a Friday night football game in Bakersfield; it was a visceral crack in the perceived safety of community events. Levi's Legacy and...

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Understanding JPMorgan's Perspective on Emerging Markets Emerging market stocks are experiencing a notable trend of underperformance, having trailed behind their developed market counterparts for four consecutive years. Analysts at JPMorgan have highlighted that since 2019, this performance gap has reached a staggering 45% in favor of developed markets. The MSCI Context...

Kinetic Expands Fiber Internet Access in Doniphan Region Kinetic, a prominent provider of fiber broadband solutions, has successfully rolled out a new nearly $1 million fiber internet network that will benefit over 300 homes and businesses in the Doniphan area. This initiative reflects Kinetic's strong commitment to improving internet connectivity in underrepresented...

Ripple Withdraws Appeal, Sparking XRP Enthusiasm The XRP market has taken significant steps forward since Ripple announced its decision to withdraw the cross-appeal in its ongoing case against the SEC. This shift has reignited optimism among investors, as evidenced by a remarkable 19% surge in the number of users engaging with the Ripplecoin Mining platform within 24...

Class Action Lawsuit Filed Against Symbotic Inc. In recent developments, a law firm recognized nationally, Bronstein, Gewirtz & Grossman, LLC, has taken a significant step by notifying investors about a class action lawsuit involving Symbotic Inc. (NASDAQ: SYM). This legal action targets certain officers of the company while focusing on protecting the interests of...

AS Ekspress Grupp's Q3 Financial Overview In the latest financial report, AS Ekspress Grupp has shared significant updates regarding its revenue and earnings. For the third quarter of 2024, the revenue observed an increase of 2%, reaching a total of EUR 16.8 million. However, the EBITDA experienced a notable decline of 19%, landing at EUR 2.0 million. Over the first nine...